Identification of novel inhibitors of the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma

被引：0
|
作者：
Kim, Yong Yean [1 ]
Hawley, Robert [2 ]
Gryder, Berkley [1 ]
Pomella, Silvia [3 ]
Kowalczyk, Josh [1 ]
Sinniah, Ranu [1 ]
Song, Young [1 ]
Khan, Javed [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] George Washington Univ, Washington, DC USA
[3] Osped Pediat Bambino Gesu, Rome, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4175
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4175
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma
    Lacey, Alexandra
    Hedrick, Erik
    Cheng, Yating
    Mohankumar, Kumaravel
    Warren, Melanie
    Safe, Stephen
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (12) : 2756 - 2766
  • [32] Small molecule inhibitors of the PAX3::FOXO1 fusion protein in rhabdomyosarcoma
    Shaw, Taryn
    Nakazawa, Kay
    Tiwari, Purushottam
    Nelson, Eryn
    Formen, Jeffrey
    Wolf, Christian
    Toretsky, Jeffrey
    Uren, Aykut
    CANCER RESEARCH, 2024, 84 (06)
  • [33] PAX3-FOXO1 and PAX3-NCOA1 fusion genes in biphenotypic sinonasal sarcoma
    Fritchie, K.
    Jin, L.
    Wang, X.
    Graham, R.
    Torbenson, M.
    Lewis, J.
    Rivera, M.
    Westendorf, J.
    Chou, M.
    Oliveira, A.
    VIRCHOWS ARCHIV, 2015, 467 : S217 - S217
  • [34] Truncated FOXO1 DNA-binding domain in Pax3-FOXO1 contributes to Pax3-FOXO1 DNA binding
    Blunt, Endia
    Paul, Manisha
    Nesbit, Jacqueline
    Johanson, Kelly
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [35] Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma
    Thanh Hung Nguyen
    Barr, Frederic G.
    MOLECULES, 2018, 23 (11):
  • [36] Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma
    Bohm, Maria
    Wachtel, Marco
    Marques, Joana G.
    Streiff, Natalie
    Laubscher, Dominik
    Nanni, Paolo
    Mamchaoui, Kamel
    Santoro, Raffaella
    Schafer, Beat W.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (11): : 4237 - 4249
  • [37] Alternate PAX3-FOXO1 Oncogenic Fusion in Biphenotypic Sinonasal Sarcoma
    Wong, Waihay J.
    Lauria, Alexandra
    Hornick, Jason L.
    Xiao, Sheng
    Fletcher, Jonathan A.
    Marino-Enriquez, Adrian
    GENES CHROMOSOMES & CANCER, 2016, 55 (01): : 25 - 29
  • [38] YAP1 AND WWTR1 REGULATE PAX3-FOXO1 TRANSCRIPTIONAL PROGRAMMING IN FUSION-POSITIVE RHABDOMYOSARCOMA
    Deel, Michael
    Rashid, Tooba
    Burgess, Breanne
    Chiu, Crystal
    Cardoza, Krislyn
    Egriboyun, Sebnem
    Linardic, Corinne
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S126 - S126
  • [39] Investigation of PAX3-FOXO1 Effect on NEAT1 Expression in Alveolar Rhabdomyosarcoma Cells
    George, Victoria Agbeke
    McDaniel, Brianyell
    Johanson, Kelly E.
    FASEB JOURNAL, 2017, 31
  • [40] Inhibiting phosphorylation of the oncogenic PAX3-FOXO1 reduces alveolar rhabdomyosarcoma phenotypes identifying novel therapy options
    Loupe, J. M.
    Miller, P. J.
    Ruffin, D. R.
    Stark, M. W.
    Hollenbach, A. D.
    ONCOGENESIS, 2015, 4 : e145 - e145
12345